| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Feb 21, 2025 | Solid Biosciences Inc. | 10% Owner | Buy | 100.0 | +1,000,000 | 24.79% | ✗ | $4M |
| May 25, 2023 | May 30, 2023 | Annexon, Inc. | 10% Owner | Buy | 92.5 | +300,000 | 5.55% | ✗ | $639.7K |
| Dec 8, 2021 | Dec 10, 2021 | Xilio Therapeutics, Inc. | 10% Owner | Buy | 85.0 | +42,469 | 1.54% | ✗ | $410.2K |
| Jul 19, 2021 | Jul 21, 2021 | RAPID MICRO BIOSYSTEMS, INC. | 10% Owner | Buy | 87.5 | +100,000 | 1.20% | ✗ | $2M |
| Jul 28, 2020 | Jul 28, 2020 | Annexon, Inc. | 10% Owner | Buy | 100.0 | +400,000 | 14.08% | ✗ | $6.8M |
| Feb 4, 2020 | Feb 6, 2020 | Arcutis Biotherapeutics, Inc. | 10% Owner | Buy | 95.0 | +294,117 | 7.98% | ✗ | $5M |
| Jul 24, 2018 | Jul 26, 2018 | Replimune Group, Inc. | 10% Owner | Buy | 100.0 | +500,000 | 21.38% | ✗ | $7.5M |